1 – 22 of 22
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines : a clinical implementation study
2024) In Breast Cancer Research and Treatment(
- Contribution to journal › Article
- 2023
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
(
- Contribution to journal › Article
- 2021
-
Mark
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
(
- Contribution to journal › Article
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
(
- Contribution to journal › Article
-
Mark
The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome
2020)(
- Working paper/Preprint › Preprint in preprint archive
- 2019
-
Mark
High patient satisfaction with a simplified BRCA1/2 testing procedure : long-term results of a prospective study
(
- Contribution to journal › Article
-
Mark
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
(
- Contribution to journal › Article
- 2018
-
Mark
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
(
- Contribution to journal › Article
-
Mark
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
(
- Contribution to journal › Article
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
(
- Contribution to journal › Article
-
Mark
BRCAsearch : written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
(
- Contribution to journal › Article
-
Mark
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression : identification of a modifier of breast cancer risk at locus 11q22.3
(
- Contribution to journal › Article
- 2013
-
Mark
Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
(
- Contribution to journal › Article
- 2011
-
Mark
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
(
- Contribution to journal › Article
- 2007
-
Mark
A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families
(
- Contribution to journal › Article
- 2003
-
Mark
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status
(
- Contribution to journal › Scientific review
-
Mark
Clinical Aspects of Hereditary Breast Cancer
2003)(
- Thesis › Doctoral thesis (compilation)
- 2001
-
Mark
Low frequency of E-cadherin alterations in familial breast cancer
(
- Contribution to journal › Article
- 2000
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
- 1999
-
Mark
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
(
- Contribution to journal › Article